Drug

Who makes phentolamine mesylate?

4 companies list phentolamine mesylate as a human prescription drug, including under the names Oraverse, Ryzumvi. Forms: injection; injection, powder, for solution; injection, solution; solution/ drops. Routes: intramuscular, intravenous, ophthalmic, submucosal.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing phentolamine mesylate

CompanyFormsApplicationNDCsRegistered sites
Hikma Pharmaceuticals USA Inc.United Statesinjection, powder, for solutionANDAANDA04023514
Precision Dose Inc.United StatesinjectionANDAANDA20768611
Septodont SASFranceinjection, solutionNDANDA02215911
Oyster Point Pharma, Inc.solution/ dropsNDANDA21706410

Bulk ingredient listings

Orange Book patents

11 unexpired patents list phentolamine mesylate as the active ingredient, expiring between Jan 2034 and Oct 2039. Application holder: FAMYGEN LIFE SCIENCES INC.

Enquiry

Common questions

Who makes phentolamine mesylate?
4 companies list phentolamine mesylate as a human prescription drug in the openFDA NDC Directory, led by Hikma Pharmaceuticals USA Inc., Precision Dose Inc., Septodont SAS, Oyster Point Pharma, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic Oraverse?
2 companies list phentolamine mesylate under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
Who supplies phentolamine mesylate active ingredient?
17 companies list phentolamine mesylate as a bulk ingredient, including Apicore US LLC, Professional Compounding Centers of America dba PCCA, AX Pharmaceutical Corp, Darmerica, LLC.